BioSpace News Archive

Business

Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections

Inspira™ Technologies OXY B.H.N. Ltd. together with Ennocure MedTech Ltd. (“Ennocure”), announced results from their collaborative development of a proprietary bio-electronic treatment to prevent associated bloodstream infections in patients in intensive care units.

April 10, 2024
·
4 min read
Business

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M

ABVC BioPharma, Inc. announced today that the Company together with its affiliates BioLite, Inc., and Rgene Corporation entered into a term sheet with OncoX BioPharma, Inc.

April 10, 2024
·
7 min read
Bexion Pharmaceuticals, Inc. Announces Poster Presentation on BXQ-350 at the American Association for Cancer Research (AACR) Annual Meeting 2024

Bexion Pharmaceuticals, Inc. announced today that the Company presented a poster on BXQ-350 during the American Association for Cancer Research (AACR) Annual Meeting 2024 which took place April 5-10, 2024, in San Diego, CA.

April 10, 2024
·
2 min read
Lone Star Bio

Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties

Moleculin Biotech, Inc. today announced positive preclinical data regarding the Company’s next-generation anthracycline, Annamycin, was presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 5-10, 2024 in San Diego, CA.

April 10, 2024
·
7 min read
Business

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Inogen, Inc. today announced that it will report first quarter 2024 financial results after the market closes on Tuesday, May 7, 2024.

April 10, 2024
·
1 min read
Business

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

Schrödinger will report its first quarter 2024 financial results on Wednesday, May 1, 2024, after the financial markets close.

April 10, 2024
·
1 min read
NEUPATH HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE

NeuPath Health Inc. today announced that Joseph Walewicz, CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference to be held April 16 to 17, 2024 at the Metro Toronto Convention Centre.

April 10, 2024
·
2 min read
Genetown

Compass Therapeutics to Participate in the Stifel Targeted Oncology Days

Compass Therapeutics, Inc. announced that the Company will participate in the Stifel Targeted Oncology Days taking place virtually April 16 – 17, 2024.

April 10, 2024
·
1 min read
Business

ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI

The companies will work together to help save gastroenterologists time by providing real-time integration between ModMed’s gGastro® ASC and Medtronic’s GI Genius™.

April 10, 2024
·
3 min read
Business

Nodexus Adds Flow Cytometry Leaders to Scientific Advisory Board

Nodexus Inc. today announced that three leading experts in cytometry sciences, pathology, and cancer biology have joined its Scientific Advisory Board (SAB).

April 10, 2024
·
4 min read